LAPAS Study: Insulin Glargine in Type 2 Diabetes Mellitus
NCT00423215
·
clinicaltrials.gov ↗
COMPLETED
Status
1007
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
Insulin glargine (LANTUS)
Sponsor
Sanofi